315 related articles for article (PubMed ID: 17763062)
21. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
22. Enzyme-responsive release of encapsulated proteins from biodegradable hollow capsules.
Itoh Y; Matsusaki M; Kida T; Akashi M
Biomacromolecules; 2006 Oct; 7(10):2715-8. PubMed ID: 17025343
[TBL] [Abstract][Full Text] [Related]
23. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
[TBL] [Abstract][Full Text] [Related]
24. Bioactive silica-based drug delivery systems containing doxorubicin hydrochloride: in vitro studies.
Prokopowicz M; Zegliński J; Gandhi A; Sawicki W; Tofail SA
Colloids Surf B Biointerfaces; 2012 May; 93():249-59. PubMed ID: 22325320
[TBL] [Abstract][Full Text] [Related]
25. A novel sol-gel-based amino-functionalized fiber for headspace solid-phase microextraction of phenol and chlorophenols from environmental samples.
Bagheri H; Babanezhad E; Khalilian F
Anal Chim Acta; 2008 May; 616(1):49-55. PubMed ID: 18471483
[TBL] [Abstract][Full Text] [Related]
26. A novel mesoporous lignin/silica hybrid from rice husk produced by a sol-gel method.
Qu Y; Tian Y; Zou B; Zhang J; Zheng Y; Wang L; Li Y; Rong C; Wang Z
Bioresour Technol; 2010 Nov; 101(21):8402-5. PubMed ID: 20594831
[TBL] [Abstract][Full Text] [Related]
27. Potential of amorphous microporous silica for ibuprofen controlled release.
Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA
Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331
[TBL] [Abstract][Full Text] [Related]
28. Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging.
Chen Y; Ai K; Liu J; Sun G; Yin Q; Lu L
Biomaterials; 2015 Aug; 60():111-20. PubMed ID: 25988726
[TBL] [Abstract][Full Text] [Related]
29. Influence of dialkyne structure on the properties of new click-gels based on hyaluronic acid.
Testa G; Di Meo C; Nardecchia S; Capitani D; Mannina L; Lamanna R; Barbetta A; Dentini M
Int J Pharm; 2009 Aug; 378(1-2):86-92. PubMed ID: 19501143
[TBL] [Abstract][Full Text] [Related]
30. Controlled release of avermectin from porous hollow silica nanoparticles.
Wen LX; Li ZZ; Zou HK; Liu AQ; Chen JF
Pest Manag Sci; 2005 Jun; 61(6):583-90. PubMed ID: 15714463
[TBL] [Abstract][Full Text] [Related]
31. Pillaring effects in macroporous carrageenan-silica composite microspheres.
Boissière M; Tourrette A; Devoisselle JM; Di Renzo F; Quignard F
J Colloid Interface Sci; 2006 Feb; 294(1):109-16. PubMed ID: 16083892
[TBL] [Abstract][Full Text] [Related]
32. Liposil, a promising composite material for drug storage and release.
Bégu S; Aubert Pouëssel A; Lerner DA; Tourné-Péteilh C; Devoisselle JM
J Control Release; 2007 Mar; 118(1):1-6. PubMed ID: 17250924
[TBL] [Abstract][Full Text] [Related]
33. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials.
Balas F; Manzano M; Horcajada P; Vallet-Regí M
J Am Chem Soc; 2006 Jun; 128(25):8116-7. PubMed ID: 16787058
[TBL] [Abstract][Full Text] [Related]
34. Microstructures and structural properties of sol-gel silica foams.
Berrier E; Zoller C; Beclin F; Turrell S; Bouazaoui M; Capoen B
J Phys Chem B; 2005 Dec; 109(48):22799-807. PubMed ID: 16853970
[TBL] [Abstract][Full Text] [Related]
35. A luminescent and mesoporous core-shell structured Gd2O3 : Eu(3+)@nSiO2@mSiO2 nanocomposite as a drug carrier.
Xu Z; Gao Y; Huang S; Ma Pa; Lin J; Fang J
Dalton Trans; 2011 May; 40(18):4846-54. PubMed ID: 21431226
[TBL] [Abstract][Full Text] [Related]
36. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
[TBL] [Abstract][Full Text] [Related]
37. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
38. Porous hydroxyapatite tablets as carriers for low-dosed drugs.
Cosijns A; Vervaet C; Luyten J; Mullens S; Siepmann F; Van Hoorebeke L; Masschaele B; Cnudde V; Remon JP
Eur J Pharm Biopharm; 2007 Sep; 67(2):498-506. PubMed ID: 17407810
[TBL] [Abstract][Full Text] [Related]
39. Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release.
Kapoor S; Hegde R; Bhattacharyya AJ
J Control Release; 2009 Nov; 140(1):34-9. PubMed ID: 19654029
[TBL] [Abstract][Full Text] [Related]
40. Release evaluation of drugs from ordered three-dimensional silica structures.
Izquierdo-Barba I; Martinez A; Doadrio AL; Pérez-Pariente J; Vallet-Regí M
Eur J Pharm Sci; 2005 Dec; 26(5):365-73. PubMed ID: 16185852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
